New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line. [electronic resource]
Producer: 20160218Description: 214-23 p. digitalISSN:- 2212-3970
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- Breast Neoplasms -- drug therapy
- Bromocriptine -- administration & dosage
- Cell Survival -- drug effects
- Dopamine Agonists -- administration & dosage
- Dopamine D2 Receptor Antagonists -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- MCF-7 Cells
- Patents as Topic
- Proliferating Cell Nuclear Antigen -- genetics
- Receptors, Dopamine D2 -- agonists
- Remoxipride -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.